Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556138 · ClinicalTrials.gov registry record · NA
Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist Candidates
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02556138: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02556138 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02556138, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Orbera Intragastric Balloon is a safe and effective means for weight loss and improved metabolic disease in patients with cirrhosis requiring liver transplantation.
Primary Outcome
The percentage of excess weight loss (%EWL) is a common metric for reporting weight loss after bariatric surgery. The %EWL can vary depending on the definitions of ideal body weight (IBW) used and the preoperative weight.
Interventions
- DEVICE ORBERA Intragastric Balloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2016-11-03 |
| Phase | NA |
Why NCT02556138 stopped before completion
NCT02556138 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ORBERA Intragastric Balloon is the first listed.
NCT02556138 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02556138 about?
NCT02556138 is a clinical study titled "Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist Candidates". The purpose of this study is to determine whether the Orbera Intragastric Balloon is a safe and effective means for weight loss and improved metabolic disease in patients with cirrhosis requiring liver transplantation.
What is the current status of trial NCT02556138?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2015-09-01. Estimated completion is 2016-11-03.
What interventions are being tested in trial NCT02556138?
The interventions under investigation include: ORBERA Intragastric Balloon (DEVICE).
Who is sponsoring clinical trial NCT02556138?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02556138's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI